Skip to main content

Beckman Coulter to Distribute Automation System for Affy Platform

NEW YORK, Oct. 28 (GenomeWeb News) - Beckman Coulter today said it would distribute an automated gene expression platform developed by Array Automation, a joint venture of Affymetrix and Beckman Coulter that was established in July.

Beckman Coulter will distribute Array Automation's new Gene Expression Automation System, which automates sample preparation and other processes for Affy's GeneChip format and can be expanded to automate Affy' new 96-well High Throughput Array.

Beckman Coulter said it would market the system to GeneChip customers through an early-access program that is currently underway in North America. Worldwide distribution will begin "as the product is commercialized," according to a company statement.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.